SEPNSepterna, Inc.

Healthcare

$40.34+79% 1Y

$40.34

$18.1052 weeks$48.13

Is it growing?

Good

Growing: revenue growing +13520% year on year and operating margin widening (+15121.7 points).

2 good, 1 without data

Revenue trend+13520% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings.

Margin direction+15121.7 points operating

Trailing-twelve-month operating margin, -41.8% now against -15163.6% a year earlier.

All from SEC EDGAR, as of Jun 30, 2026.

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is SEPN growing?

Years of annual history on file: 3
Years of annual history on file · FY2023 to FY2025, as filed

Details›

Revenue FY2023: $151K
Revenue FY2024: $1.1M
Revenue FY2025: $46M

Annual income statements as filed with the SEC.

Biotechnology

The closest names by size in the same industry

Sarepta Therapeutics, Inc.

MRVI+3.6%

Maravai LifeSciences Holdings, Inc.

MLYS-4.4%

Mineralys Therapeutics, Inc.

PVLA-1.0%

Palvella Therapeutics, Inc.

TRVI-2.6%

Trevi Therapeutics, Inc.